API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Financial Events & News API Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 134 articles Forum Github 13 repos
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. AU /
  3. SPL.AU

Starpharma Holdings Ltd (SPL AU) stock market data APIs

A$0.105 0(0%) as of September 20, 2024
Price chart is built with Anychart

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications worldwide. The company's products include VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis (BV) and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom coating. It is also involved in the development of dendrimer enhanced product (DEP) delivery platform, consisting of DEP SN38 for the treatment of ovarian and colorectal cancer that is in Phase II clinical trial; DEP cabazitaxel for prostate and ovarian cancer treatment that is in Phase II clinical trial; and DEP docetaxel to treat pancreatic and other cancers that is in Phase II clinical trial. In addition, the company is developing DEP HER2 radiodiagnostic and DEP HER2 ADC to treat solid tumors; SPL7013 for vaginal gel; and DEP HER2 radiodiagnostic. It has a collaboration agreement with Medicxi to develop petalion therapeutics, a novel cancer therapy using Starpharma's dendrimer technology. Starpharma Holdings Limited was incorporated in 1997 and is headquartered in Abbotsford, Australia.

Starpharma Holdings Ltd Financial Data Overview

0.105
0.105
-
0.105
0.1
0.086-0.195
41 737 K
417 M
9 756 K
0.771
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'SPL',
Type: 'Common Stock',
Name: 'Starpharma Holdings Ltd',
Exchange: 'AU',
CurrencyCode: 'AUD',
CurrencyName: 'Australian Dollar',
CurrencySymbol: 'A$',
CountryName: 'Australia',
CountryISO: 'AU',
OpenFigi: 'BBG000BW3JT0',
ISIN: 'AU000000SPL0',
CIK: NULL,
EmployerIdNumber: '',
FiscalYearEnd: 'June',
IPODate: NULL,
InternationalDomestic: 'International/Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

Starpharma Holdings Ltd Fundamental Data is available in our Financial Data APIs

  • Net Revenue 9 756 K
  • EBITDA -7 849 000
  • Earnings Per Share -0.02
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Starpharma Holdings Ltd Earnings via APIs

  • Latest Release 2024-08-22
  • EPS/Forecast NaN

Get Starpharma Holdings Ltd End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Starpharma Holdings Ltd latest news via APIs

Even after rising 42% this past week, Starpharma Holdings (ASX:SPL) shareholders are still down 88% over the past three years

Starpharma Holdings Limited (ASX:SPL) has rebounded strongly over the last week, with the share price soaring 42%. But only the myopic could ignore the astounding decline over three years. To wit, the...

Life Science Investor Forum: Presentations Now Available for Online Viewing

Virtual Investor Conferences Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com NEW YORK, June 23, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the lead...
Do you have any questions?
support@eodhistoricaldata.com